Tenaya Therapeutics, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Tenaya Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2020 to Q2 2024.
  • Tenaya Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $4.61M, a 20.4% increase year-over-year.
  • Tenaya Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $16.8M, a 22.6% increase year-over-year.
  • Tenaya Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $15.3M, a 33.5% increase from 2022.
  • Tenaya Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $11.5M, a 289% increase from 2021.
  • Tenaya Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $2.95M, a 298% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $16.8M $4.61M +$780K +20.4% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $16M $4.22M +$710K +20.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $15.3M $3.95M +$762K +23.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-18
Q3 2023 $14.5M $4.02M +$841K +26.5% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $13.7M $3.83M +$819K +27.2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $12.9M $3.51M +$1.42M +67.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 $11.5M $3.19M +$2.14M +204% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-18
Q3 2022 $9.33M $3.17M +$2.21M +228% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $7.12M $3.01M +$2.51M +500% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $4.61M $2.09M +$1.66M +385% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $2.95M $1.05M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-08
Q3 2021 $968K +$770K +389% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $502K +$317K +171% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 $432K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q3 2020 $198K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $185K Apr 1, 2020 Jun 30, 2020 10-Q 2021-09-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.